Literature DB >> 20970030

Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.

Arjan Vissink1, James B Mitchell, Bruce J Baum, Kirsten H Limesand, Siri Beier Jensen, Philip C Fox, Linda S Elting, Johannes A Langendijk, Robert P Coppes, Mary E Reyland.   

Abstract

The most significant long-term complication of radiotherapy in the head-and-neck region is hyposalivation and its related complaints, particularily xerostomia. This review addresses the pathophysiology underlying irradiation damage to salivary gland tissue, the consequences of radiation injury, and issues contributing to the clinical management of salivary gland hypofunction and xerostomia. These include ways to (1) prevent or minimize radiation injury of salivary gland tissue, (2) manage radiation-induced hyposalivation and xerostomia, and (3) restore the function of salivary gland tissue damaged by radiotherapy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20970030      PMCID： PMC2964345          DOI： 10.1016/j.ijrobp.2010.06.052

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  71 in total

Review 1.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-25       Impact factor: 3.603

Review 2.  Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature.

Authors:  Michael T Brennan; Linda S Elting; Fred K L Spijkervet
Journal:  Support Care Cancer       Date:  2010-03-20       Impact factor: 3.603

3.  Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

Authors:  Tim Dijkema; Cornelis P J Raaijmakers; Randall K Ten Haken; Judith M Roesink; Pètra M Braam; Anette C Houweling; Marinus A Moerland; Avraham Eisbruch; Chris H J Terhaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-07       Impact factor: 7.038

4.  Botulinum toxin prevents radiotherapy-induced salivary gland damage.

Authors:  Afshin Teymoortash; Felix Müller; Janko Juricko; Michael Bieker; Robert Mandic; Damiano Librizzi; Helmut Höffken; Andeas Pfestroff; Jochen Alfred Werner
Journal:  Oral Oncol       Date:  2009-02-11       Impact factor: 5.337

5.  Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment.

Authors:  Fred Ronald Burlage; Judith M Roesink; Hette Faber; Arjan Vissink; Johannes A Langendijk; Harm H Kampinga; Rob P Coppes
Journal:  Radiother Oncol       Date:  2007-11-19       Impact factor: 6.280

6.  Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer.

Authors:  Anke Petra Jellema; Ben J Slotman; Patricia Doornaert; C René Leemans; Johannes A Langendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-06-08       Impact factor: 7.038

7.  Investigating the relationship between hyposalivation and mucosal wetness.

Authors:  S Osailan; R Pramanik; S Shirodaria; S J Challacombe; G B Proctor
Journal:  Oral Dis       Date:  2010-10-28       Impact factor: 3.511

8.  Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

Authors:  Marije R Vergeer; Patricia A H Doornaert; Derek H F Rietveld; C René Leemans; Ben J Slotman; Johannes A Langendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-26       Impact factor: 7.038

9.  Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.

Authors:  Fred R Burlage; Judith M Roesink; Harm H Kampinga; Rob P Coppes; Chris Terhaard; Johannes A Langendijk; Peter van Luijk; Monique A Stokman; Arjan Vissink
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

10.  Rescue of salivary gland function after stem cell transplantation in irradiated glands.

Authors:  Isabelle M A Lombaert; Jeanette F Brunsting; Pieter K Wierenga; Hette Faber; Monique A Stokman; Tineke Kok; Willy H Visser; Harm H Kampinga; Gerald de Haan; Robert P Coppes
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240
View more
  107 in total

Review 1.  Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients.

Authors:  E N Klein Hesselink; T P Links
Journal:  Eur Thyroid J       Date:  2015-06-11

2.  Tyrosine Kinase Inhibitors Protect the Salivary Gland from Radiation Damage by Inhibiting Activation of Protein Kinase C-δ.

Authors:  Sten M Wie; Elizabeth Wellberg; Sana D Karam; Mary E Reyland
Journal:  Mol Cancer Ther       Date:  2017-06-21       Impact factor: 6.261

Review 3.  Dynamics of salivary gland morphogenesis.

Authors:  J Harunaga; J C Hsu; K M Yamada
Journal:  J Dent Res       Date:  2011-04-12       Impact factor: 6.116

4.  Salivary gland homeostasis is maintained through acinar cell self-duplication.

Authors:  Marit H Aure; Stephen F Konieczny; Catherine E Ovitt
Journal:  Dev Cell       Date:  2015-04-02       Impact factor: 12.270

5.  Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage.

Authors:  Sten M Wie; Tariq S Adwan; James DeGregori; Steven M Anderson; Mary E Reyland
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

6.  Artificial Induction of Native Aquaporin-1 Expression in Human Salivary Cells.

Authors:  Z Wang; S Pradhan-Bhatt; M C Farach-Carson; M J Passineau
Journal:  J Dent Res       Date:  2017-01-10       Impact factor: 6.116

Review 7.  The development of an ICF-based clinical guideline and screening tool for the standardized assessment and evaluation of functioning after head and neck cancer treatment.

Authors:  Ulrich Kisser; Christine Adderson-Kisser; Michaela Coenen; Marita Stier-Jarmer; Sven Becker; Carla Sabariego; Ulrich Harréus
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-30       Impact factor: 2.503

8.  Radiation therapy in the treatment of minor salivary gland tumors.

Authors:  Lucas R Salgado; Daniel E Spratt; Nadeem Riaz; Paul B Romesser; Suzanne Wolden; Shyam Rao; Christine Chin; Julian C Hong; Richard Wong; Nancy Y Lee
Journal:  Am J Clin Oncol       Date:  2014-10       Impact factor: 2.339

Review 9.  Targeting stem cells by radiation: From the biological angle to clinical aspects.

Authors:  Alexis Vallard; Sophie Espenel; Jean-Baptiste Guy; Peng Diao; Yaoxiong Xia; Anis El Meddeb Hamrouni; Majed Ben Mrad; Alexander Tuan Falk; Claire Rodriguez-Lafrasse; Chloé Rancoule; Nicolas Magné
Journal:  World J Stem Cells       Date:  2016-08-26       Impact factor: 5.326

10.  Loss of TRPM2 function protects against irradiation-induced salivary gland dysfunction.

Authors:  Xibao Liu; Ana Cotrim; Leyla Teos; Changyu Zheng; William Swaim; James Mitchell; Yasuo Mori; Indu Ambudkar
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.